Here's the live share price of Bacil Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bacil Pharma | -17.56 | -26.08 | -16.49 | 9.62 | 11.73 | 62.51 | 41.75 |
| Sun Pharmaceutical Industries | 1.44 | -4.47 | 2.32 | 4.28 | 10.46 | 22.15 | 22.25 |
| Divi's Laboratories | 0.09 | -2.57 | 8.34 | 4.34 | 1.82 | 22.93 | 9.69 |
| Torrent Pharmaceuticals | -2.71 | 1.17 | 3.59 | 18.26 | 37.79 | 33.76 | 25.13 |
| Cipla | -1.56 | -4.57 | 7.35 | -9.19 | -9.14 | 10.43 | 7.25 |
| Zydus Lifesciences | -2.37 | 8.91 | 20.11 | 18.13 | 12.71 | 24.86 | 11.71 |
| Dr. Reddy's Laboratories | -0.07 | -4.30 | -1.55 | -0.43 | -2.94 | 9.34 | 3.81 |
| Lupin | 0.61 | 1.55 | -0.63 | 8.01 | 17.11 | 40.48 | 14.60 |
| Mankind Pharma | 1.01 | -4.03 | 13.95 | 11.79 | 1.76 | 12.00 | 10.96 |
| Aurobindo Pharma | -2.53 | -4.97 | 12.45 | 17.95 | 28.91 | 28.18 | 8.43 |
| Laurus Labs | -1.43 | 3.27 | 39.43 | 35.01 | 106.60 | 55.46 | 18.22 |
| Biocon | -0.73 | -2.91 | 8.23 | 5.51 | 20.93 | 19.12 | 0.72 |
| Alkem Laboratories | 1.05 | -2.09 | 0.16 | -2.91 | 11.50 | 16.32 | 11.30 |
| Glenmark Pharmaceuticals | 0.26 | -8.14 | -1.67 | 9.98 | 29.50 | 49.72 | 27.39 |
| Abbott India | 0.46 | -6.21 | -0.40 | -6.03 | -16.87 | 4.32 | 9.67 |
| Anthem Biosciences | 1.80 | 0.50 | 22.48 | 18.69 | 8.70 | 2.82 | 1.68 |
| Ipca Laboratories | -4.22 | -6.15 | 0.19 | 9.56 | 13.40 | 28.46 | 9.19 |
| Ajanta Pharma | -1.40 | -3.58 | 1.32 | 19.03 | 19.99 | 28.06 | 18.96 |
| GlaxoSmithKline Pharmaceuticals | 4.43 | -8.10 | -9.83 | -13.97 | -33.15 | 15.79 | 7.70 |
| Gland Pharma | -2.54 | 4.07 | 35.08 | 34.88 | 29.62 | 29.96 | -6.09 |
Source: Dion Global
Over the last one year, Bacil Pharma has gained 11.73% compared to peers like Sun Pharmaceutical Industries (10.46%), Divi's Laboratories (1.82%), Torrent Pharmaceuticals (37.79%). From a 5 year perspective, Bacil Pharma has outperformed peers relative to Sun Pharmaceutical Industries (22.25%) and Divi's Laboratories (9.69%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 43.89 | 41.87 |
| 10 | 47.07 | 44.63 |
| 20 | 49.39 | 47.72 |
| 50 | 53.82 | 50.3 |
| 100 | 49.41 | 49.05 |
| 200 | 43.91 | 45.66 |
Source: Dion Global
In the latest quarter, Bacil Pharma saw a drop in promoter holding to 0.00%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 100.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| May 23, 2026, 02:32 AM IST IST | Bacil Pharma - Company Has Not Entered Any Related Party Transactions During The Half Year Ended 31St March, 2026. |
| May 23, 2026, 02:29 AM IST IST | Bacil Pharma - Statement Of Deviation Or Variation In Utilization Of Funds Under Regulation 32 Of The SEBI (Listing Obligatio |
| May 23, 2026, 02:19 AM IST IST | Bacil Pharma - Audited Financial Results For 31St March, 2026 |
| May 23, 2026, 02:15 AM IST IST | Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting For Audited Results For 31St March, 2026 |
| May 11, 2026, 10:50 PM IST IST | Bacil Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 22Nd May 2026 |
Source: Dion Global
Bacil Pharma Ltd. is a Public Limited Listed company incorporated on 08/05/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1987PLC043427 and registration number is 043427. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.97 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bacil Pharma is ₹40.00 as on Jun 18, 2026.
The Bacil Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Bacil Pharma is ₹57.41 Cr as on Jun 18, 2026.
Today’s highest and lowest price of Bacil Pharma are ₹40.20 and ₹39.45.
The 52-week high/low is the highest and lowest price at which Bacil Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bacil Pharma is ₹61.80 and 52-week low of Bacil Pharma is ₹26.69 as on Jun 18, 2026.
The Bacil Pharma has shown returns of 2.3% over the past day, -26.08% for the past month, -16.49% over 3 months, 11.73% over 1 year, 62.51% across 3 years, and 41.75% over 5 years.
P/E ratio of and PB ratio of Bacil Pharma are 42.78 and 2.28 on Jun 18, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global